Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « inhibitor »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
inhibition < inhibitor < inhibitors  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 55.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000009 (2008) Misato Hashizume [Japon] ; Masahiko Mihara [Japon]Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
000015 (2013) Jörg Kaufmann [Allemagne] ; Eugen Feist [Allemagne] ; Anne-Eve Roske [Allemagne] ; Wolfgang A. Schmidt [Allemagne]Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice
000038 (2016) Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study
000041 (2014) P. Jayasekera [Royaume-Uni] ; R. Parslew [Royaume-Uni] ; A. Al-Sharqi [Royaume-Uni]A case of tumour necrosis factor‐α inhibitor‐ and rituximab‐induced plantar pustular psoriasis that completely resolved with tocilizumab
000058 (2014) Lucie M. Turcotte [États-Unis] ; Colleen K. Correll ; Robyn C. Reed ; Christopher L. MoertelSustained remission of severe multicentric castleman disease following multiagent chemotherapy and tocilizumab maintenance
000067 (2010) R. Yoshiki [Japon] ; M. Nakamura [Japon] ; Y. Tokura [Japon]Drug eruption induced by IL‐6 receptor inhibitor tocilizumab
000095 (2009) Paul Emery ; Rhonda SiddallTocilizumab — IL‐6 inhibition for the treatment of rheumatoid arthritis
000142 (2010) Deal watch: BMS acquires rights for IL-6 inhibitor
000249 (2010) R. E. Fischer-Betz [Allemagne] ; M. Schneider [Allemagne]Biologika in Schwangerschaft und Stillzeit
000265 (2009) Margaret Hy [Royaume-Uni] ; Ernest Hs Choy [Royaume-Uni]Certolizumab pegol: a new option for rheumatoid arthritis
000306 (2013) Pavel Horák [République tchèque] ; Martina Skácelová [République tchèque] ; Karel Hejduk [République tchèque] ; Andrea Smržová [République tchèque] ; Karel Pavelka [République tchèque]Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic—data from the ATTRA registry
000323 (2013) P. I. Novikov [Russie] ; I. O. Smitienko [Russie] ; S. V. Moiseev [Russie]Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature
000326 (2015) Takeshi Sainoh [Japon] ; Sumihisa Orita [Japon] ; Masayuki Miyagi [Japon] ; Yoshihiro Sakuma [Japon] ; Kazuyo Yamauchi [Japon] ; Miyako Suzuki [Japon] ; Go Kubota [Japon] ; Yasuhiro Oikawa [Japon] ; Kazuhide Inage [Japon] ; Jun Sato [Japon] ; Kazuki Fujimoto [Japon] ; Yasuhiro Shiga [Japon] ; Gen Inoue [Japon] ; Yasuchika Aoki [Japon] ; Kazuhisa Takahashi [Japon] ; Seiji Ohtori [Japon]Interleukin‐6 and interleukin‐6 receptor expression, localization, and involvement in pain‐sensing neuron activation in a mouse intervertebral disc injury model
000331 (2012) Yoshikuni Mimata [Japon] ; Akihisa Kamataki ; Shinya Oikawa [Japon] ; Kenya Murakami [Japon] ; Miwa Uzuki ; Tadashi Shimamura [Japon] ; Takashi SawaiInterleukin‐6 upregulates expression of ADAMTS‐4 in fibroblast‐like synoviocytes from patients with rheumatoid arthritis
000343 (2007) Norihiro Nishimoto [Japon] ; Jun Hashimoto [Japon] ; Nobuyuki Miyasaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Shinichi Kawai [Japon] ; Tsutomu Takeuchi [Japon] ; Norikazu Murata [Japon] ; Désirée Van Der Heijde [Pays-Bas] ; Tadamitsu Kishimoto [Japon]Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
000458 (2013) A. Watik [Maroc] ; W. Rachidi [Maroc] ; S. Janani [Maroc] ; O. Mkinsi [Maroc]AB0300 Efficacy of rituximab in the treatment of rheumatoid arthritis in moroccan patients tnf alpha inhibitor-naive: a prospective study
000466 (2009) Taio Naniwa [Japon] ; Maiko Watanabe [Japon] ; Shogo Banno [Japon] ; Tomoyo Maeda [Japon]Adding low dose tacrolimus in rheumatoid arthritis patients with an inadequate response to tumor necrosis factor inhibitor therapies
000529 (2013) J.-E. Gottenberg [France] ; C. Mpofu [Suisse] ; W. Bensen [Canada] ; A. Rubbert-Roth [Allemagne] ; F. Irazoque [Mexique] ; V. Martínez Taboada [Espagne] ; C. Chung [États-Unis] ; L. Hinsch-Gylvin [Suisse] ; C. Ferri [Italie] ; P. Emery [Royaume-Uni]AB0541 Factors associated with selection of rituximab vs alternative TNF inhibitor (TNFI) following TNFI failure in patients with rheumatoid arthritis: Sub-analysis of switch-RA, a global, comparative effectiveness observational study
000617 (2013) E. V. Tchetina ; K. H. Kuzikyants ; A. Y. Devyataikina ; G. V. Lukina ; E. L. Nasonov [Russie]AB0529 Rituximab therapy monitoring by mtor, autophagy-related ULK1, caspase 3, CDK-inhibitor P21, TNF alpha, and osteoclast-specific cathepsin K and gelatinase MMP-9 gene expression in the peripheral blood of rheumatoid arthritis patients
000629 (2013) J. Nakagawa ; Y. Koyama ; T. Horiuchi [Japon] ; A. Uchino ; T. Ota ; S. NaganoFRI0188 IL-6 inhibitor or TNF inhibitor? A scoring method to predicts preferable treatment for rheumatoid arthritis
000713 (2011) M. Korppi [Finlande] ; Me Van Gijn [Pays-Bas] ; K. Antila [Finlande]Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "inhibitor" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "inhibitor" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    inhibitor
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021